| Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 51.17 | 3.85 | 4.92 | 0.00 | 1.93 |
| Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 55.11 | 4.93 | 7.75 | 1.13 | 2.11 |
| Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 68.05 | 4.00 | 12.01 | 0.00 | 4.00 |
| Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 41.12 | 4.92 | 7.15 | 0.45 | 0.89 |
| Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 40.13 | 3.49 | 6.11 | 0.00 | 0.00 |
| Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 35.46 | 0.00 | 2.53 | 0.00 | 0.00 |
| Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 19.58 | 0.63 | 0.00 | 0.00 | 0.00 |
| Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 34.74 | 2.35 | 1.04 | 0.26 | 0.00 |
| Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 21.87 | 0.49 | 1.23 | 0.00 | 0.00 |
| Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 20.93 | 1.40 | 0.00 | 0.00 | 0.00 |
| Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 57.01 | 6.12 | 2.84 | 1.09 | 0.87 |
| Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 28.22 | 3.43 | 0.79 | 0.00 | 0.00 |
| Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 27.60 | 0.99 | 0.00 | 0.12 | 0.12 |
| Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 37.12 | 2.32 | 1.33 | 0.00 | 0.33 |
| Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 24.20 | 0.67 | 2.02 | 0.67 | 0.00 |
| Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 38.57 | 0.60 | 1.21 | 0.00 | 0.00 |
| Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 24.10 | 0.73 | 1.46 | 0.00 | 0.73 |
| Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 19.52 | 1.95 | 2.44 | 0.49 | 0.00 |
| Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 42.60 | 1.85 | 1.72 | 0.12 | 0.12 |
| Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 42.23 | 1.43 | 3.88 | 0.20 | 0.41 |
| Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 41.38 | 1.25 | 0.94 | 0.63 | 0.00 |
| Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 37.78 | 2.29 | 1.43 | 0.29 | 0.29 |
| Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 62.41 | 2.33 | 1.64 | 0.27 | 0.41 |
| Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 53.86 | 2.64 | 1.63 | 0.25 | 0.13 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basophils, donor1.CNhs12546.12241-129G9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basophils, donor2.CNhs12563.12242-129H1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basophils, donor3.CNhs12575.12243-129H2 | 6.19 | 0.15 | 0.15 | 0.00 | 0.15 |
| Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 19.31 | 2.76 | 0.00 | 0.00 | 0.00 |
| Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 25.30 | 0.90 | 0.60 | 0.00 | 0.00 |
| Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 24.40 | 1.11 | 0.37 | 0.00 | 0.00 |
| Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 0.29 | 0.00 | 0.00 | 0.29 | 0.00 |
| CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 1.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 0.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 8.48 | 0.61 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 1.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 1.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 0.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 117.03 | 2.44 | 0.00 | 0.00 | 0.00 |
| Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 40.91 | 1.34 | 0.67 | 0.00 | 0.00 |
| Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 29.54 | 4.35 | 3.84 | 0.00 | 0.77 |
| Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 39.40 | 4.34 | 1.08 | 0.72 | 0.00 |
| Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 38.10 | 2.01 | 2.51 | 0.50 | 0.00 |
| Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 43.60 | 4.92 | 2.90 | 0.29 | 0.72 |
| Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 15.91 | 1.59 | 0.80 | 0.80 | 0.00 |
| Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 40.39 | 1.95 | 0.97 | 0.00 | 0.00 |
| Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 56.44 | 1.70 | 1.23 | 0.57 | 0.19 |
| Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 69.40 | 1.55 | 2.22 | 0.22 | 0.89 |
| Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 55.51 | 1.58 | 3.34 | 0.35 | 0.97 |
| Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 29.60 | 2.23 | 0.59 | 1.18 | 0.20 |
| Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 18.21 | 2.55 | 0.00 | 0.00 | 0.00 |
| Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 22.99 | 1.48 | 0.00 | 0.37 | 0.00 |
| Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 9.74 | 0.40 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 11.18 | 0.86 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 13.89 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 16.39 | 0.57 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 15.94 | 0.84 | 0.00 | 0.00 | 0.42 |
| Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 15.41 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 11.70 | 0.00 | 0.00 | 0.21 | 0.00 |
| Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 21.45 | 0.26 | 0.00 | 0.26 | 0.26 |
| Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 20.99 | 1.42 | 0.00 | 0.71 | 0.00 |
| Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 29.79 | 0.33 | 0.00 | 0.33 | 0.33 |
| Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 6.04 | 0.81 | 0.00 | 0.00 | 0.40 |
| Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 6.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 12.69 | 0.49 | 0.24 | 0.00 | 0.00 |
| Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 13.60 | 0.00 | 0.00 | 0.37 | 0.00 |
| Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 13.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 24.65 | 0.45 | 0.09 | 0.18 | 0.00 |
| Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 28.96 | 0.22 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 19.59 | 0.34 | 0.11 | 0.11 | 0.00 |
| Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 16.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 8.54 | 0.00 | 0.00 | 0.00 | 0.00 |
| Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 12.09 | 0.37 | 0.18 | 0.18 | 0.00 |
| Eosinophils, donor2.CNhs12548.12245-129H4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eosinophils, donor3.CNhs12549.12246-129H5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 6.98 | 2.18 | 0.00 | 0.00 | 0.00 |
| Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 64.61 | 5.47 | 3.98 | 0.50 | 1.49 |
| Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 47.61 | 3.42 | 2.41 | 0.00 | 0.38 |
| Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 48.46 | 6.36 | 1.59 | 0.13 | 0.53 |
| Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 95.52 | 5.16 | 2.87 | 0.00 | 0.57 |
| Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 60.29 | 2.48 | 0.71 | 0.35 | 0.00 |
| Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 39.81 | 1.68 | 2.80 | 0.00 | 0.00 |
| Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 26.69 | 4.27 | 1.07 | 0.00 | 0.00 |
| Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 25.41 | 0.99 | 0.99 | 0.00 | 0.00 |
| Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 50.10 | 3.73 | 3.42 | 0.31 | 0.00 |
| Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 36.78 | 1.48 | 0.81 | 0.27 | 0.13 |
| Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 49.53 | 0.82 | 1.14 | 0.16 | 0.16 |
| Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 40.41 | 1.21 | 4.24 | 0.61 | 0.30 |
| Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 57.62 | 0.58 | 4.03 | 0.58 | 1.15 |
| Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 40.54 | 3.28 | 1.41 | 0.47 | 0.00 |
| Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 38.71 | 4.68 | 0.00 | 0.31 | 0.00 |
| Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 22.82 | 1.71 | 0.00 | 0.00 | 0.00 |
| Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 32.73 | 3.59 | 0.30 | 0.00 | 0.15 |
| Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 74.34 | 2.58 | 0.23 | 0.12 | 0.00 |
| Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 90.16 | 2.43 | 1.29 | 0.32 | 0.00 |
| Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 73.32 | 3.23 | 1.69 | 0.00 | 0.56 |
| Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 61.86 | 4.08 | 0.61 | 0.20 | 0.20 |
| Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 67.44 | 2.95 | 0.74 | 0.25 | 0.12 |
| Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 75.43 | 4.65 | 0.83 | 0.31 | 0.00 |
| Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 98.60 | 8.32 | 7.13 | 0.00 | 0.00 |
| Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 107.56 | 9.89 | 7.67 | 0.99 | 1.48 |
| Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 30.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 36.65 | 2.87 | 0.72 | 0.00 | 0.00 |
| Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 64.64 | 2.86 | 0.84 | 0.17 | 0.51 |
| Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 93.21 | 2.88 | 0.63 | 0.00 | 0.13 |
| Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 80.90 | 8.59 | 2.22 | 0.00 | 0.55 |
| Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 101.84 | 6.15 | 4.83 | 0.00 | 0.00 |
| Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 76.62 | 5.82 | 7.05 | 0.00 | 1.23 |
| Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 71.06 | 11.87 | 5.56 | 0.75 | 1.05 |
| Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 25.86 | 1.70 | 1.36 | 0.00 | 0.34 |
| Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 128.26 | 4.84 | 6.64 | 0.00 | 0.90 |
| Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 81.79 | 8.12 | 5.34 | 0.85 | 0.85 |
| Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 82.02 | 5.09 | 2.97 | 0.21 | 0.21 |
| Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 122.44 | 3.60 | 3.30 | 0.00 | 0.60 |
| Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 87.59 | 4.43 | 4.84 | 0.41 | 0.31 |
| Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 94.81 | 4.90 | 5.67 | 0.00 | 0.77 |
| Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 66.82 | 5.21 | 3.72 | 0.19 | 0.56 |
| Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 96.20 | 5.06 | 3.21 | 0.51 | 0.34 |
| Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 63.33 | 3.61 | 5.07 | 0.10 | 0.39 |
| Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 124.70 | 7.57 | 6.56 | 0.25 | 0.76 |
| Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 92.60 | 4.88 | 3.68 | 0.64 | 0.09 |
| Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 64.50 | 4.36 | 2.75 | 1.94 | 0.16 |
| Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 104.73 | 7.10 | 6.39 | 0.00 | 0.71 |
| Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 57.53 | 3.63 | 5.84 | 0.40 | 0.40 |
| Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 58.84 | 4.75 | 3.22 | 0.34 | 0.68 |
| Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 29.18 | 1.93 | 0.77 | 0.00 | 0.00 |
| Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 31.37 | 1.09 | 0.00 | 0.00 | 0.00 |
| Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 30.69 | 1.72 | 1.43 | 0.00 | 0.29 |
| H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 21.35 | 1.10 | 0.24 | 0.12 | 0.24 |
| H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 27.30 | 0.53 | 0.27 | 0.53 | 0.27 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 26.49 | 0.93 | 0.46 | 0.00 | 0.00 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 29.13 | 1.35 | 0.62 | 0.10 | 0.10 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 19.43 | 0.76 | 0.25 | 0.00 | 0.00 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 41.97 | 1.09 | 0.73 | 0.00 | 0.00 |
| Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 68.84 | 1.56 | 4.69 | 0.00 | 1.56 |
| Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 71.40 | 1.29 | 9.01 | 0.00 | 1.93 |
| Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 30.39 | 1.38 | 1.38 | 0.00 | 1.38 |
| Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 47.83 | 7.89 | 7.43 | 0.93 | 1.39 |
| Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 31.76 | 4.33 | 5.05 | 0.00 | 2.17 |
| Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 54.78 | 3.08 | 4.97 | 0.00 | 1.42 |
| Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 65.24 | 3.71 | 2.19 | 0.67 | 1.18 |
| Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 59.77 | 5.54 | 4.82 | 0.48 | 0.72 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 57.68 | 4.74 | 4.30 | 0.33 | 1.32 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 51.86 | 6.32 | 3.49 | 0.44 | 1.31 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 60.50 | 6.88 | 2.61 | 0.00 | 0.47 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 45.03 | 3.51 | 1.75 | 0.27 | 0.54 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 59.46 | 4.71 | 3.14 | 0.39 | 1.18 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 53.10 | 4.23 | 2.31 | 0.77 | 0.77 |
| Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 11.07 | 0.00 | 0.74 | 0.00 | 0.00 |
| Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 21.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 24.69 | 4.53 | 2.06 | 0.00 | 0.00 |
| Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 27.93 | 7.35 | 1.47 | 0.00 | 0.00 |
| Hepatocyte, donor1.CNhs12340.11523-119I2 | 44.36 | 1.27 | 1.27 | 0.00 | 0.00 |
| Hepatocyte, donor2.CNhs12349.11603-120I1 | 31.45 | 0.98 | 0.00 | 0.00 | 0.00 |
| Hepatocyte, donor3.CNhs12626.11684-122I1 | 44.31 | 0.59 | 0.00 | 0.00 | 0.00 |
| Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 32.96 | 2.71 | 0.49 | 0.25 | 0.12 |
| Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 38.26 | 1.89 | 1.72 | 0.00 | 0.51 |
| Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 29.96 | 2.85 | 0.55 | 0.00 | 0.00 |
| Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 26.98 | 2.25 | 0.00 | 0.00 | 0.00 |
| Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 35.89 | 2.81 | 0.70 | 0.00 | 0.10 |
| Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 30.46 | 1.57 | 0.28 | 0.00 | 0.09 |
| Keratocytes, donor1.CNhs11337.11527-119I6 | 26.39 | 1.30 | 0.65 | 0.33 | 0.98 |
| Keratocytes, donor2.CNhs12095.11607-120I5 | 50.96 | 2.08 | 0.00 | 0.00 | 0.00 |
| Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 31.75 | 2.89 | 0.00 | 0.00 | 0.00 |
| Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 23.65 | 1.04 | 0.12 | 0.35 | 0.00 |
| Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 50.96 | 4.23 | 6.81 | 0.59 | 2.58 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 9.96 | 0.43 | 0.14 | 0.00 | 0.00 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 10.65 | 0.00 | 0.00 | 0.00 | 0.00 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 14.08 | 0.57 | 0.00 | 0.00 | 0.00 |
| MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 17.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 12.02 | 1.72 | 0.00 | 0.00 | 0.00 |
| Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 18.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 35.28 | 2.02 | 1.01 | 0.00 | 0.00 |
| Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 24.53 | 1.84 | 0.28 | 0.00 | 0.00 |
| Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 48.18 | 2.60 | 0.81 | 0.18 | 0.00 |
| Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 32.55 | 1.74 | 0.29 | 0.00 | 0.29 |
| Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 27.99 | 1.92 | 0.77 | 0.00 | 0.00 |
| Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 1.97 | 0.00 | 0.49 | 0.00 | 0.00 |
| Mast cell, donor1.CNhs12566.11563-120D6 | 0.35 | 0.09 | 0.00 | 0.00 | 0.00 |
| Mast cell, donor2.CNhs12594.11565-120D8 | 6.01 | 0.21 | 0.21 | 0.00 | 0.00 |
| Mast cell, donor3.CNhs12593.11566-120D9 | 5.62 | 0.00 | 0.00 | 0.14 | 0.00 |
| Mast cell, donor4.CNhs12592.11567-120E1 | 6.94 | 0.13 | 0.00 | 0.00 | 0.00 |
| Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 24.26 | 0.57 | 0.25 | 0.19 | 0.13 |
| Melanocyte - light, donor1.CNhs11303.11274-116H5 | 29.41 | 1.91 | 2.29 | 0.38 | 0.00 |
| Melanocyte - light, donor2.CNhs11383.11351-117H1 | 35.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Melanocyte - light, donor3.CNhs12033.11423-118G1 | 34.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 40.82 | 2.26 | 1.85 | 0.21 | 1.34 |
| Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 60.67 | 2.40 | 7.51 | 1.50 | 1.50 |
| Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 80.89 | 3.14 | 2.00 | 0.57 | 0.29 |
| Meningeal Cells, donor1.CNhs11320.11493-119E8 | 36.11 | 0.90 | 4.71 | 0.00 | 0.78 |
| Meningeal Cells, donor2.CNhs12080.11573-120E7 | 18.75 | 0.87 | 0.44 | 0.00 | 0.00 |
| Meningeal Cells, donor3.CNhs12731.11654-122E7 | 46.57 | 0.81 | 2.93 | 0.00 | 0.37 |
| Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 62.57 | 4.65 | 2.84 | 0.39 | 0.39 |
| Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 35.77 | 7.15 | 0.00 | 0.00 | 0.00 |
| Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 44.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 65.95 | 9.04 | 2.66 | 0.80 | 0.27 |
| Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 82.17 | 6.24 | 8.32 | 1.04 | 1.04 |
| Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 24.18 | 2.31 | 0.77 | 0.00 | 0.00 |
| Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 25.53 | 1.42 | 1.42 | 0.00 | 0.00 |
| Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 33.30 | 1.60 | 0.53 | 0.00 | 0.00 |
| Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 62.34 | 4.86 | 2.57 | 0.71 | 0.29 |
| Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 31.47 | 5.43 | 1.09 | 1.63 | 0.00 |
| Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 32.93 | 1.65 | 0.00 | 0.00 | 0.82 |
| Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 24.10 | 0.65 | 0.00 | 0.00 | 0.00 |
| Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 44.42 | 5.33 | 4.26 | 0.00 | 1.42 |
| Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 53.06 | 4.75 | 0.79 | 0.00 | 1.58 |
| Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 33.16 | 3.92 | 1.21 | 0.30 | 0.00 |
| Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 33.99 | 2.61 | 0.87 | 0.00 | 0.87 |
| Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 40.19 | 4.30 | 3.00 | 0.40 | 0.60 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 33.55 | 3.83 | 3.59 | 0.48 | 0.72 |
| Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 45.94 | 3.45 | 4.59 | 0.00 | 1.15 |
| Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 84.16 | 2.85 | 0.00 | 1.43 | 0.00 |
| Myoblast, donor1.CNhs10870.11241-116D8 | 50.38 | 4.05 | 3.91 | 0.14 | 0.87 |
| Myoblast, donor2.CNhs11965.11322-117D8 | 69.45 | 1.23 | 1.64 | 0.21 | 0.21 |
| Myoblast, donor3.CNhs11908.11398-118D3 | 67.33 | 2.51 | 1.97 | 0.18 | 1.43 |
| NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Neural stem cells, donor1.CNhs11063.11275-116H6 | 60.22 | 2.80 | 4.57 | 2.29 | 1.02 |
| Neural stem cells, donor2.CNhs11384.11352-117H2 | 44.25 | 1.30 | 2.60 | 1.30 | 0.00 |
| Neurons, donor1.CNhs12338.11494-119E9 | 34.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Neurons, donor2.CNhs12726.11574-120E8 | 21.78 | 1.01 | 0.50 | 0.34 | 0.17 |
| Neurons, donor3.CNhs13815.11655-122E8 | 36.36 | 0.64 | 0.00 | 0.64 | 0.64 |
| Neutrophils, donor1.CNhs10862.11233-116C9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Neutrophils, donor2.CNhs11959.11314-117C9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Neutrophils, donor3.CNhs11905.11390-118C4 | 0.00 | 0.41 | 0.00 | 0.00 | 0.00 |
| Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 37.18 | 3.07 | 1.35 | 0.49 | 0.00 |
| Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 40.01 | 1.00 | 1.00 | 0.00 | 0.00 |
| Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 32.28 | 2.17 | 0.54 | 1.63 | 0.27 |
| Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 63.85 | 8.11 | 10.19 | 1.66 | 1.66 |
| Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 80.65 | 6.42 | 6.60 | 0.54 | 1.25 |
| Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 98.72 | 11.20 | 10.72 | 0.95 | 2.21 |
| Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 137.76 | 17.92 | 6.44 | 1.41 | 0.70 |
| Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 28.59 | 1.50 | 0.60 | 0.30 | 0.00 |
| Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 27.29 | 2.27 | 0.00 | 0.00 | 0.00 |
| Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 21.73 | 2.07 | 1.03 | 0.00 | 0.00 |
| Osteoblast, donor2.CNhs11385.11354-117H4 | 64.43 | 3.32 | 1.99 | 0.66 | 0.00 |
| Osteoblast, donor3.CNhs12036.11426-118G4 | 56.97 | 3.87 | 2.58 | 0.18 | 0.37 |
| Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 71.94 | 5.91 | 2.00 | 0.26 | 0.35 |
| Pericytes, donor1.CNhs11317.11491-119E6 | 12.92 | 0.20 | 0.20 | 0.00 | 0.20 |
| Pericytes, donor2.CNhs12079.11571-120E5 | 13.73 | 0.69 | 0.69 | 0.34 | 0.34 |
| Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 17.58 | 3.33 | 1.21 | 0.00 | 0.91 |
| Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 19.97 | 1.66 | 0.00 | 0.00 | 0.00 |
| Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 23.59 | 2.42 | 1.81 | 0.30 | 0.30 |
| Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 52.85 | 2.48 | 5.95 | 0.00 | 0.50 |
| Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 70.13 | 6.29 | 8.75 | 0.31 | 1.38 |
| Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 56.97 | 3.65 | 10.38 | 0.28 | 1.68 |
| Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 55.36 | 4.36 | 7.82 | 0.64 | 1.41 |
| Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 55.26 | 5.12 | 7.68 | 1.02 | 3.07 |
| Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 45.20 | 5.47 | 9.01 | 0.16 | 1.13 |
| Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 26.72 | 0.00 | 5.94 | 0.00 | 0.00 |
| Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 66.46 | 1.70 | 0.62 | 0.15 | 0.00 |
| Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 44.39 | 1.60 | 1.78 | 0.00 | 0.53 |
| Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 66.03 | 2.22 | 0.99 | 0.41 | 0.16 |
| Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 74.25 | 0.52 | 1.04 | 0.00 | 0.00 |
| Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 49.27 | 2.67 | 0.93 | 0.23 | 0.12 |
| Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 34.69 | 2.30 | 0.97 | 0.12 | 0.24 |
| Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 39.70 | 3.01 | 0.60 | 0.00 | 0.20 |
| Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 45.30 | 3.04 | 0.09 | 0.00 | 0.00 |
| Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 50.52 | 2.53 | 2.18 | 0.11 | 0.23 |
| Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 65.19 | 6.01 | 0.73 | 0.18 | 0.55 |
| Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 49.17 | 7.21 | 1.97 | 1.05 | 0.00 |
| Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 20.30 | 3.16 | 0.90 | 0.45 | 0.00 |
| Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 50.14 | 2.46 | 0.54 | 0.00 | 0.08 |
| Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 39.22 | 1.57 | 0.00 | 0.00 | 1.57 |
| Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 16.08 | 1.46 | 1.46 | 0.00 | 1.46 |
| Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 46.23 | 0.95 | 0.32 | 0.00 | 0.21 |
| Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 15.92 | 0.00 | 0.00 | 0.00 | 0.00 |
| Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 16.33 | 0.00 | 0.00 | 0.00 | 0.00 |
| Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 49.88 | 1.08 | 0.65 | 0.00 | 0.00 |
| Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 37.01 | 0.00 | 1.54 | 0.00 | 0.00 |
| Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 20.05 | 1.08 | 0.00 | 0.00 | 0.00 |
| Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 12.04 | 1.00 | 0.00 | 0.50 | 0.00 |
| Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 31.60 | 3.82 | 0.25 | 0.00 | 0.00 |
| Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 35.74 | 4.16 | 0.83 | 0.00 | 0.00 |
| Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 35.82 | 1.79 | 0.67 | 0.00 | 0.00 |
| Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 25.13 | 2.05 | 2.56 | 0.26 | 0.77 |
| Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 14.10 | 2.30 | 5.90 | 0.66 | 1.31 |
| Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 23.10 | 1.30 | 4.56 | 0.33 | 0.65 |
| SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 39.98 | 2.58 | 1.24 | 0.62 | 1.65 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 39.56 | 1.47 | 0.09 | 0.00 | 0.37 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 36.96 | 1.24 | 0.17 | 0.08 | 0.08 |
| Sebocyte, donor1.CNhs10847.11220-116B5 | 16.65 | 2.30 | 0.00 | 0.00 | 0.57 |
| Sebocyte, donor2.CNhs11951.11301-117B5 | 18.20 | 1.95 | 0.65 | 0.00 | 0.00 |
| Sertoli Cells, donor1.CNhs10851.11255-116F4 | 38.56 | 9.64 | 1.61 | 0.00 | 1.61 |
| Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 48.34 | 1.84 | 1.45 | 0.29 | 0.10 |
| Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 49.45 | 1.69 | 0.77 | 0.00 | 0.15 |
| Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 62.63 | 0.61 | 1.54 | 0.00 | 0.31 |
| Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 61.06 | 2.89 | 2.21 | 0.14 | 0.55 |
| Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 58.44 | 2.69 | 0.75 | 0.11 | 0.00 |
| Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 65.11 | 2.03 | 1.60 | 0.29 | 0.15 |
| Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 53.10 | 2.47 | 1.79 | 0.09 | 0.51 |
| Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 36.86 | 3.83 | 3.47 | 0.71 | 0.80 |
| Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 27.44 | 0.50 | 0.17 | 0.00 | 0.00 |
| Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 38.25 | 1.73 | 0.96 | 0.00 | 0.38 |
| Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 96.48 | 5.74 | 0.51 | 0.26 | 0.00 |
| Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 27.72 | 1.52 | 0.40 | 0.00 | 0.10 |
| Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 64.15 | 3.25 | 1.86 | 0.46 | 0.00 |
| Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 67.37 | 3.15 | 3.46 | 0.00 | 0.31 |
| Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 31.37 | 2.09 | 1.39 | 1.39 | 0.00 |
| Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 48.36 | 2.77 | 1.54 | 0.31 | 0.31 |
| Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 15.44 | 1.60 | 0.53 | 0.00 | 0.53 |
| Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 51.33 | 3.48 | 0.00 | 0.00 | 0.00 |
| Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 17.42 | 0.56 | 0.74 | 0.00 | 0.19 |
| Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 30.63 | 2.29 | 2.15 | 0.00 | 0.72 |
| Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 37.96 | 3.35 | 7.07 | 0.37 | 1.12 |
| Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 37.97 | 2.53 | 3.48 | 0.32 | 0.00 |
| Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 69.39 | 6.29 | 7.24 | 0.57 | 2.10 |
| Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 15.87 | 2.05 | 0.26 | 0.00 | 0.26 |
| Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 72.75 | 2.14 | 0.43 | 1.71 | 0.43 |
| Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 30.87 | 1.27 | 0.32 | 0.32 | 0.64 |
| Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 19.62 | 1.57 | 0.78 | 0.00 | 0.00 |
| Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 53.42 | 4.86 | 4.32 | 0.18 | 0.00 |
| Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 67.81 | 4.12 | 4.67 | 0.00 | 0.55 |
| Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 56.43 | 4.12 | 2.47 | 0.12 | 0.35 |
| Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 17.19 | 1.21 | 1.01 | 0.20 | 0.40 |
| Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 28.53 | 1.59 | 0.00 | 1.59 | 1.59 |
| Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 34.54 | 0.00 | 0.00 | 0.00 | 0.42 |
| Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 23.41 | 1.95 | 1.46 | 0.00 | 0.00 |
| Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 41.68 | 0.97 | 1.46 | 0.24 | 0.00 |
| Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 24.30 | 2.11 | 0.00 | 0.00 | 0.00 |
| Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 49.82 | 3.96 | 2.59 | 0.27 | 0.00 |
| Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 69.85 | 4.38 | 2.97 | 0.85 | 0.57 |
| Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 35.03 | 6.78 | 1.13 | 1.13 | 0.00 |
| Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 49.62 | 1.65 | 2.21 | 0.00 | 0.55 |
| Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 29.19 | 1.99 | 1.99 | 0.00 | 0.00 |
| Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 28.50 | 2.19 | 1.75 | 0.00 | 0.44 |
| Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 9.26 | 1.16 | 1.74 | 0.00 | 0.00 |
| Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 50.50 | 2.62 | 0.66 | 0.00 | 0.00 |
| Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 16.64 | 1.01 | 0.41 | 0.20 | 0.00 |
| Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 22.00 | 0.93 | 1.24 | 0.00 | 0.62 |
| Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 33.24 | 1.41 | 0.56 | 0.00 | 0.00 |
| Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 56.22 | 3.44 | 1.58 | 0.00 | 0.14 |
| Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 36.55 | 5.70 | 4.03 | 0.00 | 0.79 |
| Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 14.62 | 1.78 | 1.07 | 0.00 | 0.00 |
| Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 45.41 | 2.84 | 0.35 | 0.00 | 0.00 |
| Synoviocyte, donor2.CNhs11992.11368-117I9 | 40.32 | 3.59 | 1.27 | 0.21 | 0.42 |
| Synoviocyte, donor3.CNhs12050.11440-118H9 | 51.70 | 2.63 | 0.99 | 0.33 | 0.66 |
| Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 48.95 | 1.52 | 0.38 | 0.00 | 0.00 |
| Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 81.88 | 4.90 | 3.15 | 0.35 | 0.00 |
| Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 24.34 | 1.44 | 0.00 | 0.00 | 0.00 |
| Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 22.12 | 0.67 | 0.00 | 0.00 | 0.00 |
| Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 30.49 | 2.18 | 0.00 | 0.00 | 0.00 |
| Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 39.63 | 1.69 | 1.41 | 0.56 | 0.94 |
| Urothelial Cells, donor1.CNhs11334.11520-119H8 | 20.66 | 0.86 | 0.43 | 0.00 | 0.00 |
| Urothelial Cells, donor2.CNhs12091.11600-120H7 | 11.79 | 0.00 | 1.68 | 0.00 | 0.00 |
| Urothelial Cells, donor3.CNhs12122.11681-122H7 | 17.74 | 1.33 | 0.00 | 0.00 | 0.00 |
| Urothelial cells, donor0.CNhs10843.11216-116B1 | 29.40 | 1.15 | 0.46 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 11.32 | 2.14 | 1.92 | 0.32 | 0.85 |
| Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 68.34 | 18.29 | 29.84 | 4.81 | 16.36 |
| acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 57.09 | 6.86 | 1.96 | 0.00 | 1.23 |
| acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 4.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 1.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 4.68 | 0.43 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 5.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 3.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 4.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 0.98 | 0.20 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 8.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 7.86 | 1.12 | 0.00 | 0.00 | 0.00 |
| adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 65.05 | 5.13 | 1.03 | 0.73 | 0.15 |
| adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 23.91 | 2.06 | 0.49 | 0.00 | 0.12 |
| adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 4.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 66.77 | 1.99 | 0.57 | 0.00 | 0.00 |
| amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 61.12 | 8.12 | 2.86 | 0.48 | 8.12 |
| amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 52.86 | 5.05 | 2.38 | 2.08 | 1.48 |
| amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 71.57 | 6.45 | 1.23 | 0.00 | 0.00 |
| amygdala - adult, donor10196.CNhs13793.10167-103B5 | 13.92 | 0.00 | 0.00 | 0.00 | 0.00 |
| amygdala, adult, donor10252.CNhs12311.10151-102I7 | 37.42 | 0.28 | 0.00 | 0.56 | 0.14 |
| anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 50.76 | 1.78 | 0.11 | 0.22 | 0.11 |
| anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 12.85 | 0.33 | 0.00 | 0.00 | 0.00 |
| anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 53.41 | 3.17 | 0.42 | 0.00 | 0.00 |
| aorta, adult, pool1.CNhs11760.10052-101G7 | 32.28 | 2.79 | 0.00 | 0.80 | 0.20 |
| appendix, adult.CNhs12842.10189-103D9 | 25.69 | 2.76 | 0.83 | 3.59 | 0.00 |
| argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 46.36 | 0.00 | 0.00 | 0.00 | 0.25 |
| astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 36.31 | 0.61 | 0.51 | 0.00 | 0.00 |
| b cell line:RPMI1788.CNhs10744.10427-106D4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 34.53 | 6.84 | 4.67 | 0.31 | 0.93 |
| bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 67.94 | 2.61 | 0.90 | 0.00 | 0.18 |
| bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 35.80 | 1.97 | 0.36 | 0.36 | 0.18 |
| biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| bladder, adult, pool1.CNhs10616.10011-101C2 | 55.73 | 7.79 | 1.28 | 14.40 | 0.49 |
| blood, adult, pool1.CNhs11761.10053-101G8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 61.13 | 3.33 | 5.56 | 0.00 | 0.00 |
| brain, adult, donor1.CNhs11796.10084-102B3 | 17.45 | 0.97 | 0.97 | 0.00 | 0.00 |
| brain, adult, pool1.CNhs10617.10012-101C3 | 18.18 | 0.37 | 0.28 | 0.28 | 0.00 |
| brain, fetal, pool1.CNhs11797.10085-102B4 | 13.97 | 0.00 | 0.00 | 0.00 | 0.00 |
| breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 13.80 | 0.26 | 0.00 | 0.26 | 0.26 |
| breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 0.70 | 0.00 | 0.00 | 0.00 | 0.00 |
| breast, adult, donor1.CNhs11792.10080-102A8 | 92.80 | 8.70 | 0.72 | 0.00 | 0.00 |
| bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 29.24 | 2.62 | 0.34 | 0.00 | 0.00 |
| bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 31.78 | 2.03 | 0.00 | 0.00 | 0.00 |
| bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 26.71 | 1.42 | 3.55 | 1.89 | 2.84 |
| carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 14.48 | 0.00 | 0.00 | 0.00 | 0.69 |
| carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 23.04 | 0.58 | 0.00 | 0.00 | 0.00 |
| carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 94.80 | 1.74 | 1.04 | 0.17 | 0.17 |
| caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 30.12 | 0.00 | 0.00 | 1.77 | 0.00 |
| caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 25.08 | 0.36 | 0.00 | 0.72 | 0.00 |
| cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 19.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 33.73 | 0.33 | 0.11 | 0.66 | 0.22 |
| cerebellum, adult, pool1.CNhs11795.10083-102B2 | 21.28 | 0.59 | 0.00 | 0.59 | 0.00 |
| cerebral meninges, adult.CNhs12840.10188-103D8 | 19.74 | 1.32 | 0.44 | 0.00 | 0.22 |
| cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 65.25 | 16.45 | 11.11 | 2.07 | 2.07 |
| cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 46.85 | 2.65 | 0.00 | 0.42 | 0.00 |
| cervix, adult, pool1.CNhs10618.10013-101C4 | 51.71 | 3.54 | 0.38 | 5.16 | 0.00 |
| cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 44.44 | 0.91 | 0.57 | 0.11 | 0.00 |
| choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 63.41 | 8.30 | 17.52 | 0.92 | 20.75 |
| choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 58.88 | 7.72 | 12.48 | 1.44 | 7.36 |
| choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 25.86 | 5.76 | 10.21 | 1.30 | 8.26 |
| chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 44.34 | 18.18 | 16.27 | 0.64 | 25.52 |
| chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 56.52 | 6.60 | 6.23 | 0.46 | 7.14 |
| chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 41.04 | 11.19 | 13.86 | 2.67 | 31.98 |
| chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 10.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 7.65 | 0.20 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 10.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 11.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 32.92 | 2.32 | 0.21 | 0.00 | 0.00 |
| clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 83.90 | 5.06 | 2.45 | 0.33 | 0.82 |
| colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 31.52 | 4.95 | 1.13 | 0.14 | 0.71 |
| colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 52.80 | 1.08 | 0.22 | 0.43 | 0.22 |
| colon, adult, donor1.CNhs11794.10082-102B1 | 53.74 | 4.98 | 0.00 | 5.97 | 0.00 |
| colon, adult, pool1.CNhs10619.10014-101C5 | 39.89 | 3.98 | 0.53 | 10.61 | 0.27 |
| colon, fetal, donor1.CNhs11780.10070-101I7 | 46.44 | 3.67 | 2.44 | 4.28 | 0.00 |
| cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 19.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 6.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 8.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 28.98 | 0.54 | 0.34 | 0.74 | 0.00 |
| diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 65.01 | 11.24 | 0.80 | 2.41 | 0.80 |
| diencephalon, adult.CNhs12610.10193-103E4 | 17.34 | 0.70 | 0.23 | 1.41 | 0.00 |
| diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 28.18 | 1.57 | 0.20 | 0.00 | 0.39 |
| ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 34.96 | 0.97 | 0.49 | 0.24 | 0.00 |
| ductus deferens, adult.CNhs12846.10196-103E7 | 43.01 | 0.79 | 0.00 | 1.18 | 0.00 |
| duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 53.24 | 0.00 | 1.21 | 1.21 | 0.00 |
| temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 29.08 | 0.00 | 0.00 | 0.31 | 0.00 |
| dura mater, adult, donor1.CNhs10648.10041-101F5 | 31.59 | 2.27 | 1.52 | 0.82 | 0.51 |
| embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 41.79 | 0.30 | 0.15 | 0.00 | 0.15 |
| embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 24.57 | 0.41 | 0.10 | 0.00 | 0.00 |
| embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 18.61 | 1.33 | 0.00 | 0.00 | 0.00 |
| embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 30.78 | 1.65 | 0.00 | 0.00 | 0.00 |
| embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 21.35 | 2.20 | 0.31 | 0.00 | 0.31 |
| embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 8.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 22.48 | 0.28 | 0.57 | 0.28 | 0.00 |
| endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 32.87 | 3.74 | 0.14 | 0.28 | 0.00 |
| endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 18.74 | 2.08 | 0.52 | 0.00 | 0.00 |
| epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 44.19 | 1.86 | 0.20 | 0.10 | 0.10 |
| epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 51.63 | 2.96 | 0.87 | 0.00 | 0.09 |
| epididymis, adult.CNhs12847.10197-103E8 | 32.32 | 2.10 | 0.35 | 2.80 | 0.00 |
| epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 48.67 | 4.47 | 0.86 | 0.00 | 0.17 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 74.02 | 4.74 | 4.26 | 0.58 | 0.48 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 102.91 | 7.82 | 5.63 | 0.66 | 1.17 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 68.81 | 3.45 | 3.78 | 0.66 | 0.90 |
| esophagus, adult, pool1.CNhs10620.10015-101C6 | 38.60 | 4.27 | 1.36 | 1.94 | 0.10 |
| extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 37.07 | 6.97 | 3.62 | 0.35 | 0.71 |
| eye, fetal, donor1.CNhs11762.10054-101G9 | 30.51 | 1.36 | 0.00 | 0.68 | 0.00 |
| fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 46.46 | 3.43 | 0.27 | 0.14 | 0.55 |
| fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 80.48 | 1.39 | 0.20 | 0.40 | 0.00 |
| frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 17.35 | 0.38 | 0.13 | 0.25 | 0.00 |
| gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 75.87 | 3.91 | 2.15 | 0.00 | 0.98 |
| gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 34.31 | 1.76 | 0.16 | 0.08 | 0.00 |
| gall bladder, adult.CNhs12848.10198-103E9 | 36.50 | 7.47 | 0.64 | 6.40 | 0.00 |
| gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 85.52 | 1.20 | 1.20 | 0.20 | 0.20 |
| gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 7.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 29.09 | 4.70 | 1.37 | 0.80 | 0.69 |
| gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 83.40 | 0.51 | 0.17 | 0.00 | 0.00 |
| giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 42.93 | 2.88 | 1.30 | 0.00 | 0.00 |
| giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 81.14 | 4.47 | 0.99 | 0.12 | 0.50 |
| glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 58.22 | 2.36 | 1.41 | 0.24 | 0.47 |
| glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 53.68 | 5.16 | 2.17 | 0.68 | 0.68 |
| glioblastoma cell line:A172.CNhs11185.10444-106F3 | 69.14 | 4.08 | 2.20 | 0.42 | 0.73 |
| glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 68.03 | 1.53 | 1.02 | 0.00 | 0.00 |
| glioma cell line:GI-1.CNhs10731.10413-106B8 | 47.97 | 0.29 | 0.00 | 0.00 | 0.00 |
| globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 22.22 | 0.00 | 0.00 | 0.60 | 0.00 |
| globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 32.31 | 0.27 | 0.00 | 0.82 | 0.00 |
| granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 99.28 | 1.29 | 2.15 | 0.00 | 0.00 |
| hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 1.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| heart - mitral valve, adult.CNhs12855.10205-103F7 | 55.58 | 3.91 | 0.56 | 1.68 | 0.00 |
| heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 51.33 | 6.65 | 0.00 | 1.37 | 0.00 |
| heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 63.89 | 0.72 | 0.00 | 1.44 | 0.00 |
| heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 30.75 | 2.00 | 0.60 | 0.40 | 1.00 |
| heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 30.05 | 3.43 | 0.00 | 1.72 | 0.00 |
| heart, adult, pool1.CNhs10621.10016-101C7 | 48.65 | 7.36 | 1.12 | 3.57 | 0.00 |
| heart, fetal, pool1.CNhs10653.10046-101G1 | 64.90 | 10.88 | 3.09 | 4.57 | 0.27 |
| hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 47.92 | 8.65 | 6.13 | 0.00 | 0.00 |
| hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 2.33 | 2.33 | 0.00 | 0.00 | 0.00 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 18.20 | 1.73 | 0.39 | 0.24 | 0.08 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 18.21 | 1.15 | 0.41 | 0.16 | 0.00 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 19.88 | 1.55 | 0.34 | 0.27 | 0.00 |
| hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 45.97 | 0.69 | 0.00 | 0.00 | 0.10 |
| hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 29.42 | 0.00 | 0.00 | 3.18 | 0.00 |
| hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 53.39 | 0.82 | 0.00 | 0.95 | 0.00 |
| iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 46.30 | 1.61 | 1.77 | 0.80 | 0.48 |
| iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 37.69 | 2.61 | 1.10 | 0.28 | 0.69 |
| iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 38.22 | 2.49 | 2.08 | 0.00 | 0.42 |
| immature langerhans cells, donor1.CNhs13537.11904-125F5 | 1.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| immature langerhans cells, donor2.CNhs13480.11905-125F6 | 10.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| insula, adult, pool1.CNhs10646.10039-101F3 | 18.77 | 0.30 | 0.06 | 0.24 | 0.00 |
| keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 12.41 | 0.34 | 0.34 | 0.00 | 0.00 |
| kidney, adult, pool1.CNhs10622.10017-101C8 | 55.56 | 2.36 | 0.55 | 0.95 | 0.08 |
| kidney, fetal, pool1.CNhs10652.10045-101F9 | 51.83 | 2.31 | 0.63 | 0.52 | 0.37 |
| large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 87.44 | 2.75 | 0.95 | 0.53 | 0.11 |
| large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 53.07 | 1.61 | 0.72 | 0.00 | 0.00 |
| large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 37.62 | 2.88 | 0.96 | 0.00 | 0.38 |
| left atrium, adult, donor1.CNhs11790.10079-102A7 | 41.45 | 5.72 | 0.71 | 0.71 | 0.00 |
| left ventricle, adult, donor1.CNhs11789.10078-102A6 | 37.08 | 10.59 | 0.66 | 3.31 | 0.00 |
| leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 27.72 | 7.63 | 6.10 | 0.76 | 0.51 |
| leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 33.12 | 1.09 | 1.09 | 0.54 | 0.00 |
| leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 31.11 | 1.73 | 1.73 | 0.00 | 0.00 |
| leiomyoma cell line:15425.CNhs11724.10571-108B4 | 38.21 | 1.63 | 0.98 | 0.00 | 0.00 |
| lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 29.93 | 0.00 | 0.00 | 0.00 | 0.00 |
| leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 78.89 | 3.58 | 1.70 | 0.17 | 0.68 |
| liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 64.25 | 2.38 | 1.81 | 0.68 | 1.02 |
| liver, adult, pool1.CNhs10624.10018-101C9 | 32.53 | 0.29 | 0.00 | 0.00 | 0.15 |
| liver, fetal, pool1.CNhs11798.10086-102B5 | 27.83 | 0.00 | 0.00 | 1.33 | 0.00 |
| locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 33.36 | 0.13 | 0.00 | 1.03 | 0.26 |
| locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 33.19 | 0.13 | 0.00 | 0.40 | 0.00 |
| lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 53.38 | 3.76 | 3.59 | 0.00 | 0.51 |
| lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 19.03 | 0.70 | 0.00 | 0.00 | 0.00 |
| lung, adult, pool1.CNhs10625.10019-101D1 | 38.34 | 4.27 | 0.64 | 0.96 | 0.32 |
| lung, fetal, donor1.CNhs11680.10068-101I5 | 67.76 | 4.24 | 0.47 | 2.67 | 0.00 |
| lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 36.45 | 2.49 | 0.41 | 0.00 | 0.41 |
| lymph node, adult, donor1.CNhs11788.10077-102A5 | 10.92 | 1.49 | 0.00 | 0.00 | 0.00 |
| lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 31.42 | 0.20 | 0.00 | 0.00 | 0.00 |
| lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 51.07 | 0.64 | 0.64 | 0.64 | 0.00 |
| mature adipocyte, donor1.CNhs12558.12231-129F8 | 135.46 | 16.32 | 2.72 | 3.26 | 0.00 |
| mature adipocyte, donor2.CNhs12559.12232-129F9 | 136.63 | 15.29 | 2.51 | 1.00 | 0.00 |
| mature adipocyte, donor3.CNhs12560.12233-129G1 | 139.69 | 10.11 | 0.92 | 1.84 | 0.92 |
| mature adipocyte, donor4.CNhs12562.12234-129G2 | 131.48 | 8.20 | 0.66 | 0.66 | 0.33 |
| maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 36.59 | 0.16 | 0.00 | 0.47 | 0.00 |
| medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 20.38 | 1.77 | 0.00 | 0.89 | 0.00 |
| medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 21.60 | 0.49 | 0.12 | 0.12 | 0.00 |
| medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 34.05 | 0.38 | 0.00 | 0.25 | 0.13 |
| medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 25.23 | 1.15 | 1.15 | 1.72 | 0.00 |
| medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 39.93 | 1.44 | 0.67 | 2.11 | 0.11 |
| medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 30.30 | 0.75 | 0.19 | 0.99 | 0.12 |
| medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 128.80 | 1.38 | 0.42 | 0.28 | 0.00 |
| medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 69.11 | 3.25 | 1.75 | 0.00 | 0.37 |
| melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 49.29 | 1.82 | 0.61 | 0.00 | 0.15 |
| melanoma cell line:G-361.CNhs11254.10465-106H6 | 67.94 | 6.28 | 4.28 | 2.28 | 0.86 |
| meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 59.05 | 0.71 | 0.24 | 0.00 | 0.24 |
| merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 40.28 | 0.94 | 0.00 | 0.00 | 0.00 |
| merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 58.11 | 0.72 | 0.29 | 0.58 | 0.14 |
| mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 49.55 | 1.64 | 0.75 | 0.00 | 0.45 |
| mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 53.05 | 1.40 | 2.34 | 0.00 | 0.70 |
| mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 51.04 | 0.55 | 0.00 | 0.00 | 0.00 |
| mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 42.43 | 2.08 | 0.00 | 0.00 | 0.00 |
| mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 38.74 | 1.51 | 0.50 | 0.50 | 0.00 |
| mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 48.94 | 2.67 | 0.00 | 0.00 | 0.00 |
| mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 23.80 | 1.37 | 1.83 | 0.00 | 0.23 |
| mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 52.33 | 1.97 | 1.06 | 0.30 | 0.00 |
| mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 57.98 | 1.87 | 0.78 | 0.16 | 0.31 |
| mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 41.99 | 0.44 | 0.15 | 0.15 | 0.00 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 56.55 | 1.59 | 0.32 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 33.74 | 0.45 | 0.00 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 53.41 | 1.71 | 0.62 | 0.00 | 0.16 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 65.94 | 1.66 | 0.83 | 0.41 | 0.00 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 40.14 | 2.39 | 0.80 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 55.83 | 1.57 | 3.65 | 1.04 | 0.00 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 48.68 | 1.80 | 0.60 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 65.88 | 6.47 | 1.90 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 52.89 | 1.22 | 1.63 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 44.19 | 0.91 | 0.73 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 46.40 | 0.97 | 0.21 | 0.11 | 0.11 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 58.00 | 2.78 | 0.00 | 0.00 | 0.00 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 74.05 | 5.97 | 5.57 | 0.40 | 0.80 |
| mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 108.01 | 2.00 | 6.40 | 0.00 | 2.40 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 76.58 | 2.40 | 2.75 | 0.69 | 1.72 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 73.07 | 5.39 | 4.04 | 1.35 | 0.67 |
| mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 42.90 | 3.79 | 6.31 | 1.26 | 0.00 |
| mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 58.56 | 2.70 | 0.77 | 0.00 | 0.19 |
| mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 49.11 | 5.58 | 5.58 | 1.29 | 2.14 |
| mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 50.63 | 1.30 | 1.30 | 0.00 | 0.00 |
| mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 85.24 | 6.57 | 2.27 | 0.00 | 0.45 |
| mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 47.23 | 2.78 | 0.23 | 0.00 | 0.23 |
| mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 78.32 | 2.69 | 3.67 | 0.49 | 0.00 |
| mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 78.98 | 1.79 | 1.61 | 0.00 | 0.00 |
| mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 58.67 | 3.71 | 3.71 | 0.00 | 0.62 |
| mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 65.13 | 2.85 | 5.48 | 0.66 | 0.88 |
| mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 70.15 | 1.41 | 1.06 | 0.35 | 0.00 |
| mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 56.91 | 2.70 | 2.12 | 0.19 | 0.77 |
| mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 80.08 | 3.04 | 2.37 | 0.68 | 0.17 |
| mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 39.20 | 0.51 | 0.77 | 0.26 | 0.26 |
| mesothelioma cell line:No36.CNhs13074.10857-111G2 | 53.54 | 4.15 | 10.36 | 0.00 | 1.38 |
| mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 72.62 | 2.73 | 2.43 | 0.30 | 0.00 |
| middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 33.60 | 0.28 | 0.00 | 0.00 | 0.00 |
| migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 1.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 53.07 | 0.98 | 0.66 | 0.00 | 0.33 |
| mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 82.58 | 3.44 | 0.98 | 0.00 | 0.25 |
| mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 59.17 | 3.80 | 0.00 | 0.00 | 0.42 |
| mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 1.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| myeloma cell line:PCM6.CNhs11258.10474-106I6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 66.40 | 4.54 | 0.57 | 0.00 | 0.57 |
| myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 69.41 | 1.47 | 0.74 | 0.55 | 0.00 |
| nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 29.93 | 2.24 | 0.00 | 0.00 | 0.00 |
| nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 42.30 | 1.87 | 0.00 | 0.00 | 0.62 |
| neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 32.36 | 0.26 | 0.13 | 0.00 | 0.26 |
| neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 53.80 | 2.59 | 1.40 | 0.54 | 0.22 |
| neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 26.26 | 0.47 | 0.16 | 0.00 | 0.00 |
| neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 60.61 | 1.31 | 0.11 | 0.76 | 0.22 |
| neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 22.74 | 0.68 | 0.17 | 0.00 | 0.00 |
| neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 76.74 | 0.85 | 0.21 | 0.00 | 0.21 |
| neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 32.35 | 0.37 | 0.00 | 0.12 | 0.00 |
| neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 36.31 | 0.56 | 1.12 | 0.00 | 0.56 |
| neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 71.23 | 7.31 | 5.41 | 0.32 | 0.64 |
| non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 56.04 | 1.60 | 0.00 | 0.00 | 0.00 |
| normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 56.43 | 8.46 | 4.58 | 0.35 | 1.06 |
| normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 63.70 | 3.06 | 3.98 | 0.31 | 0.92 |
| nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 19.40 | 0.51 | 0.13 | 0.77 | 0.06 |
| occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 29.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 37.67 | 0.32 | 0.00 | 0.32 | 0.00 |
| occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 18.87 | 0.62 | 0.21 | 0.62 | 0.00 |
| occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 24.70 | 0.50 | 0.00 | 0.50 | 0.00 |
| occipital pole, adult, pool1.CNhs10643.10036-101E9 | 12.31 | 0.41 | 0.00 | 0.48 | 0.00 |
| olfactory region, adult.CNhs12611.10195-103E6 | 22.12 | 0.16 | 0.16 | 0.81 | 0.00 |
| optic nerve, donor1.CNhs13449.10277-104E7 | 21.42 | 1.43 | 0.00 | 1.43 | 0.00 |
| oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 27.19 | 0.79 | 0.00 | 0.29 | 0.00 |
| oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 26.90 | 1.06 | 0.12 | 0.00 | 0.00 |
| oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 38.70 | 2.02 | 0.00 | 0.18 | 0.18 |
| oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 33.62 | 1.39 | 1.27 | 0.12 | 0.12 |
| osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 83.52 | 4.58 | 5.72 | 0.38 | 1.14 |
| osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 33.14 | 0.69 | 1.38 | 0.00 | 0.00 |
| osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 30.43 | 0.20 | 0.20 | 0.20 | 0.00 |
| ovary, adult, pool1.CNhs10626.10020-101D2 | 32.42 | 2.03 | 0.30 | 2.11 | 0.30 |
| pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 45.79 | 1.41 | 0.20 | 0.00 | 0.20 |
| pancreas, adult, donor1.CNhs11756.10049-101G4 | 15.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 14.93 | 2.62 | 4.45 | 0.79 | 3.93 |
| papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 92.37 | 8.02 | 15.56 | 0.98 | 4.26 |
| papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 57.52 | 3.84 | 0.44 | 0.15 | 0.15 |
| paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 17.56 | 0.07 | 0.14 | 0.47 | 0.00 |
| parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 25.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 34.10 | 0.21 | 0.21 | 0.41 | 0.00 |
| parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 16.68 | 0.51 | 0.19 | 0.06 | 0.19 |
| parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 35.01 | 1.09 | 0.00 | 0.00 | 0.00 |
| parotid gland, adult.CNhs12849.10199-103F1 | 8.77 | 0.00 | 0.00 | 0.55 | 0.00 |
| penis, adult.CNhs12850.10200-103F2 | 49.62 | 2.48 | 0.99 | 3.47 | 0.50 |
| peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 48.89 | 0.35 | 0.18 | 0.00 | 0.00 |
| pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 33.73 | 2.68 | 1.15 | 0.26 | 0.38 |
| pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 6.43 | 0.00 | 0.00 | 0.54 | 0.00 |
| pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 8.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 49.16 | 1.21 | 0.00 | 2.43 | 0.00 |
| pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 76.49 | 0.68 | 0.46 | 1.37 | 0.23 |
| placenta, adult, pool1.CNhs10627.10021-101D3 | 22.53 | 3.19 | 3.81 | 0.89 | 3.90 |
| plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 48.19 | 1.37 | 0.51 | 0.34 | 0.00 |
| pons, adult, pool1.CNhs10640.10033-101E6 | 13.39 | 0.20 | 0.00 | 0.20 | 0.00 |
| postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 16.05 | 0.46 | 0.00 | 0.20 | 0.00 |
| prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 49.88 | 4.25 | 2.01 | 0.12 | 0.24 |
| prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 40.82 | 1.11 | 0.44 | 0.11 | 0.22 |
| prostate, adult, pool1.CNhs10628.10022-101D4 | 46.47 | 5.65 | 1.26 | 9.73 | 0.31 |
| putamen, adult, donor10196.CNhs12324.10176-103C5 | 20.11 | 0.47 | 0.16 | 0.63 | 0.16 |
| rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 30.27 | 1.12 | 0.56 | 0.00 | 0.56 |
| rectum, fetal, donor1.CNhs11777.10067-101I4 | 81.27 | 8.22 | 0.91 | 2.74 | 0.00 |
| renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 44.05 | 3.24 | 0.86 | 0.00 | 0.22 |
| renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 22.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| retina, adult, pool1.CNhs10636.10030-101E3 | 53.04 | 2.57 | 0.71 | 2.00 | 0.29 |
| retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 40.29 | 0.79 | 0.16 | 0.00 | 0.16 |
| rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 22.32 | 1.98 | 0.58 | 0.00 | 0.12 |
| rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 46.59 | 2.09 | 1.22 | 0.00 | 0.70 |
| sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 89.79 | 6.41 | 4.01 | 0.00 | 1.60 |
| salivary acinar cells, donor1.CNhs12810.11771-123I7 | 48.07 | 2.69 | 0.62 | 0.21 | 0.00 |
| salivary acinar cells, donor2.CNhs12811.11772-123I8 | 67.09 | 2.73 | 0.68 | 0.00 | 0.00 |
| salivary acinar cells, donor3.CNhs12812.11773-123I9 | 62.90 | 2.77 | 0.00 | 0.69 | 0.00 |
| salivary gland, adult, pool1.CNhs11677.10093-102C3 | 15.92 | 0.00 | 0.00 | 0.86 | 0.00 |
| schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 37.27 | 1.18 | 0.12 | 0.24 | 0.00 |
| schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 49.25 | 1.79 | 0.34 | 0.17 | 0.00 |
| seminal vesicle, adult.CNhs12851.10201-103F3 | 33.87 | 2.96 | 0.00 | 2.12 | 0.00 |
| serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 43.76 | 1.60 | 1.60 | 0.92 | 0.69 |
| serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 26.99 | 0.62 | 0.31 | 0.00 | 0.00 |
| serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 38.22 | 0.96 | 0.00 | 0.96 | 0.00 |
| serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 50.45 | 3.36 | 3.80 | 0.67 | 0.45 |
| signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 19.14 | 0.20 | 0.00 | 0.10 | 0.20 |
| signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 11.09 | 0.12 | 0.12 | 0.00 | 0.00 |
| skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 23.31 | 13.60 | 1.29 | 2.59 | 0.65 |
| skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 60.37 | 17.25 | 3.59 | 4.93 | 1.54 |
| skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 38.27 | 4.64 | 0.00 | 0.00 | 1.16 |
| skin, fetal, donor1.CNhs11774.10065-101I2 | 39.83 | 1.46 | 0.49 | 1.46 | 0.00 |
| small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 81.41 | 1.40 | 0.23 | 0.47 | 0.47 |
| small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 93.11 | 0.60 | 0.80 | 0.00 | 0.00 |
| small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 26.52 | 1.31 | 0.71 | 0.00 | 0.00 |
| small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 52.41 | 1.02 | 0.68 | 0.45 | 0.00 |
| small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 57.61 | 0.22 | 0.11 | 0.00 | 0.00 |
| small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 81.37 | 2.26 | 1.21 | 1.21 | 0.30 |
| small intestine, adult, pool1.CNhs10630.10024-101D6 | 25.78 | 1.54 | 0.23 | 1.70 | 0.00 |
| small intestine, fetal, donor1.CNhs11773.10064-101I1 | 28.63 | 1.53 | 0.00 | 1.09 | 0.22 |
| small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 65.37 | 0.47 | 0.00 | 0.00 | 0.00 |
| smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 49.27 | 13.97 | 2.21 | 19.61 | 2.21 |
| somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 21.92 | 0.47 | 0.00 | 0.24 | 0.00 |
| spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 34.16 | 0.39 | 0.00 | 0.39 | 0.00 |
| spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 40.10 | 0.00 | 0.00 | 0.30 | 0.59 |
| spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 47.34 | 4.23 | 0.42 | 0.00 | 0.00 |
| spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 65.42 | 8.67 | 7.31 | 0.17 | 1.02 |
| spleen, adult, pool1.CNhs10631.10025-101D7 | 11.00 | 1.41 | 0.19 | 0.19 | 0.00 |
| spleen, fetal, pool1.CNhs10651.10044-101F8 | 19.08 | 1.68 | 0.19 | 0.19 | 0.00 |
| splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 17.68 | 0.54 | 0.00 | 0.00 | 0.00 |
| squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 67.76 | 1.06 | 0.35 | 0.00 | 0.00 |
| squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 22.95 | 0.72 | 0.08 | 0.08 | 0.00 |
| stomach, fetal, donor1.CNhs11771.10062-101H8 | 26.29 | 5.11 | 0.73 | 2.19 | 1.46 |
| submaxillary gland, adult.CNhs12852.10202-103F4 | 21.10 | 0.92 | 0.00 | 0.92 | 0.00 |
| substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 35.26 | 0.72 | 0.14 | 0.72 | 0.00 |
| synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 40.23 | 4.73 | 1.89 | 0.32 | 0.47 |
| temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 15.03 | 0.54 | 0.07 | 0.27 | 0.07 |
| temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 24.00 | 0.44 | 0.00 | 0.00 | 0.00 |
| duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 50.79 | 1.59 | 0.00 | 2.12 | 0.00 |
| tenocyte, donor1.CNhs12639.11763-123H8 | 56.92 | 4.46 | 0.37 | 0.74 | 0.00 |
| tenocyte, donor2.CNhs12640.11765-123I1 | 47.60 | 1.39 | 0.92 | 0.46 | 0.00 |
| tenocyte, donor3.CNhs12641.11768-123I4 | 48.02 | 0.87 | 0.00 | 0.87 | 0.00 |
| teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 31.42 | 1.26 | 0.88 | 0.00 | 0.25 |
| teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 36.28 | 0.87 | 0.55 | 0.00 | 0.22 |
| teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 14.44 | 1.65 | 0.51 | 0.13 | 0.25 |
| testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 6.94 | 0.92 | 0.61 | 0.20 | 0.61 |
| testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 14.70 | 0.53 | 0.27 | 0.00 | 0.53 |
| testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 17.28 | 1.47 | 0.92 | 0.00 | 0.09 |
| testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 1.00 | 0.25 | 0.00 | 0.00 | 0.00 |
| testis, adult, pool1.CNhs10632.10026-101D8 | 30.46 | 1.82 | 0.38 | 0.83 | 0.08 |
| testis, adult, pool2.CNhs12998.10096-102C6 | 29.21 | 1.07 | 1.07 | 0.54 | 0.00 |
| thalamus - adult, donor10196.CNhs13794.10168-103B6 | 33.17 | 0.00 | 0.00 | 1.66 | 0.00 |
| thalamus, adult, donor10252.CNhs12314.10154-103A1 | 37.96 | 0.10 | 0.00 | 0.83 | 0.00 |
| throat, adult.CNhs12858.10209-103G2 | 44.14 | 6.18 | 1.92 | 3.20 | 0.21 |
| throat, fetal, donor1.CNhs11770.10061-101H7 | 54.28 | 3.57 | 0.95 | 0.95 | 0.48 |
| thymus, adult, pool1.CNhs10633.10027-101D9 | 4.00 | 0.06 | 0.00 | 0.06 | 0.00 |
| thymus, fetal, pool1.CNhs10650.10043-101F7 | 12.17 | 0.37 | 0.06 | 0.12 | 0.00 |
| thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 56.18 | 2.13 | 1.57 | 0.11 | 0.11 |
| thyroid, adult, pool1.CNhs10634.10028-101E1 | 38.19 | 1.65 | 0.06 | 0.25 | 0.13 |
| thyroid, fetal, donor1.CNhs11769.10060-101H6 | 69.12 | 2.63 | 0.00 | 2.22 | 0.00 |
| tongue, adult.CNhs12853.10203-103F5 | 50.51 | 4.14 | 0.00 | 1.31 | 0.44 |
| tongue, fetal, donor1.CNhs11768.10059-101H5 | 37.65 | 5.13 | 1.03 | 2.05 | 0.34 |
| tonsil, adult, pool1.CNhs10654.10047-101G2 | 21.75 | 1.41 | 0.20 | 0.47 | 0.07 |
| trachea, adult, pool1.CNhs10635.10029-101E2 | 33.06 | 1.15 | 0.14 | 0.65 | 0.07 |
| trachea, fetal, donor1.CNhs11766.10058-101H4 | 59.55 | 2.66 | 0.00 | 0.67 | 0.33 |
| transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 49.41 | 1.06 | 0.81 | 0.33 | 0.08 |
| transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 37.67 | 1.92 | 1.17 | 0.11 | 0.11 |
| tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 77.23 | 5.79 | 0.00 | 0.00 | 0.00 |
| tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 23.26 | 0.45 | 0.09 | 0.45 | 0.18 |
| umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 42.24 | 2.35 | 2.35 | 4.69 | 0.00 |
| uterus, adult, pool1.CNhs11676.10100-102D1 | 54.03 | 3.18 | 0.73 | 2.81 | 0.37 |
| uterus, fetal, donor1.CNhs11763.10055-101H1 | 59.41 | 3.66 | 0.00 | 0.81 | 0.41 |
| vagina, adult.CNhs12854.10204-103F6 | 68.57 | 12.65 | 0.67 | 11.32 | 0.67 |
| vein, adult.CNhs12844.10191-103E2 | 27.17 | 1.81 | 0.20 | 0.81 | 0.00 |
| xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 8.01 | 0.00 | 0.00 | 0.00 | 0.00 |
JASPAR motif:MA0090.1
